# Post-Vaccination Assessment of Peste Des Petits Ruminants in Sheep and Goats in the United Arab Emirates

## TL;DR

A study in the UAE found that a PPR vaccine significantly increased immunity in sheep and goats, exceeding global guidelines, and recommends continued mass vaccination to eradicate the disease.

## Contribution

Demonstrated that a PPR vaccine achieved higher herd immunity than the global threshold, supporting eradication efforts.

## Key findings

- Post-vaccination seroprevalence increased from 52.32% to 93.77% in small ruminants.
- 93.87% of vaccinated epi-units achieved over 70% seroprevalence post-vaccination.
- Prediction analysis suggests UAE Emirates can reach full immune protection within 1.2 years.

## Abstract

Peste des petits ruminants (PPR) post-vaccination monitoring was carried out at a national level in the United Arab Emirates (UAE) in 2024 in accordance with the Global Control and Eradication Strategy (GCES) guidelines. Two serosurveys conducted pre and post the national mass PPR vaccination revealed the use of an efficient PPR vaccine to immunize sheep and goats which resulted in higher post-vaccination herd immunity than the threshold recommended by the PPR GCES. Mass vaccination of sheep and goats with a target over 95% coverage is recommended for the next three years to achieve the sustained desired level of immunity at the holding level.

Background: Peste des petits ruminants (PPR) is an acute or subacute contagious trans-boundary viral disease causing high morbidity and mortality in domestic and wild small ruminants. The national UAE-PPR control and eradication plan follows the PPR Global Control and Eradication Strategy (PPR GCES) and relies on the annual mass vaccination of small ruminants to eradicate the disease from the country by 2030. Despite the immunization effort against PPR, the vaccination coverage reached 65% at maximum, which necessitates conducting a post-vaccination evaluation (PVE) study at the national level. Methods: Using multistage random sampling to assess the PPR vaccine and vaccination effectiveness, protocol (2) of the PPR GCES, using two serosurveys; serosurvey (1) (pre-vaccination) at day 0 before vaccination, to assess the primary PPR serological investigation, and serosurvey (2) at (30–90) days post-PPR vaccination, to evaluate the immune response, were carried out from September to December 2024 across the seven Emirates of the UAE. The nucleoprotein-based competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect PPR antibodies in a total of 1592 and 1589 sera samples collected, respectively, before and after vaccination from different (n = 163) sheep and goats holdings (epi-unit) distributed in the different Emirates of the UAE. Results: In serosurvey (1). prior to vaccination, out of the total 1592 samples tested (839 goats and 753 sheep), 833 animals (52.32%) were found to be seropositive for PPR antibodies. In contrast, in serosurvey (2), after vaccination, 1490 (93.77%) animals were found to be seropositive out of the total 1589 small ruminants (825 goats and 764 sheep) tested by c-ELISA. A statistically significant increase (41.45%) in the overall seroprevalence from (52.32%) pre-vaccination to (93.77%) post-vaccination was observed. Post-vaccination, 93.87% (n = 153) of the vaccinated epi-units achieved more than 70% seroprevalence compared to 43.56% (n = 71) before vaccination. Prediction analysis showed that all the seven UAE Emirates require 1.2 years maximum to reach 100% immune-protection levels. Conclusions: An efficient PPR vaccine was used to immunize small ruminants in the UAE. Higher (89.47–100%) post-vaccination herd immunity than the threshold recommended by the PPR GCES (>80% immunity) was attained, which can efficiently break the spread of PPRV within the UAE. To enhance the eradication of PPR I the UAE, conducting mass vaccination campaigns targeting over the (95%) immunization coverage of eligible animals for the next three years is recommended to attain the requested sustained (>80%) immunity at the animals holding level.